Pelvic organ prolapse affects up to 40% of women over 40, with anterior compartment prolapse representing the most common form. Despite surgical advances, choosing the optimal repair technique remains contentious, directly impacting millions of women facing this quality-of-life diminishing condition.
This comprehensive Cochrane review analyzed 41 randomized trials involving 4,531 women, comparing surgical approaches for anterior compartment prolapse repair. The analysis revealed that native tissue repair techniques carry a 53% higher risk of recurrent prolapse compared to biological graft methods over 1-2 years post-surgery. Specifically, when baseline recurrence rates sit at 21%, native tissue approaches push failure rates to approximately 32%. However, both methods showed equivalent patient-reported awareness of prolapse symptoms, suggesting anatomical outcomes don't always correlate with subjective experiences.
These findings illuminate a critical trade-off in pelvic reconstructive surgery. While biological grafts demonstrate superior anatomical durability, the clinical significance remains nuanced given similar symptom profiles between approaches. The moderate certainty evidence suggests surgeons and patients must weigh recurrence risk against other factors like cost, surgical complexity, and potential mesh-related complications not fully captured in these trials. For the growing population of aging women, this research underscores that surgical decision-making extends beyond simple prolapse prevention to encompass broader quality-of-life considerations. The evidence gaps identified here highlight an ongoing need for longer-term studies examining patient-centered outcomes rather than purely anatomical success metrics.